Your browser doesn't support javascript.
loading
Establishing reference intervals for von Willebrand factor multimers.
Pikta, Marika; Vasse, Marc; Smock, Kristi J; Moser, Karen A; van, Dievoet Marie-Astrid; Lejniece, Sandra; Szanto, Timea; Bautista, Hector; Nouadje, George; Banys, Valdas.
Afiliación
  • Pikta M; North Estonia Medical Centre, Department of Laboratory Medicine, Tallinn, Estonia.
  • Vasse M; Foch Hospital, Department of Biology & UMR INSERM 1176, Suresnes, France.
  • Smock KJ; University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA.
  • Moser KA; University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA.
  • van DM; Cliniques Universitaires Saint-Luc, Laboratory Department, Bruxelles, Belgium.
  • Lejniece S; Riga Stradins University, Riga, Latvia.
  • Szanto T; Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Department of Hematology, Coagulation Disorders Unit, Helsinki, Finland.
  • Bautista H; Sebia, Research and Developments Department, Lisses - Evry Cedex, France.
  • Nouadje G; Sebia, Research and Developments Department, Lisses - Evry Cedex, France.
  • Banys V; Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Vilnius, Lithuania.
J Med Biochem ; 41(1): 115-121, 2022 Feb 02.
Article en En | MEDLINE | ID: mdl-35431650
ABSTRACT

Background:

von Willebrand factor (VWF) multimers (VWFMM) methodologies are technically difficult, laborious, time consuming, non-standardized and results vary between laboratories. A new semi automated VWFMM assay is available for routine use (Sebia). Due to lack of reference values for VWFMM fractions, results interpretation can be challenging in some cases. The aim of this study was to determine reference intervals for low molecular weight (LMWM), intermediate molecular weight (IMWM) and high molecular weight (HMWM) multimers.

Methods:

By the international cooperation initiated between 4 countries (Estonia, Latvia, France, and USA) 131 samples of relatively healthy individuals were analyzed for VWFMM (in total 51 males and 80 non-pregnant females aged 17-69 years). Reference intervals were calculated according to CLSI C28-A3 standard.

Results:

The proposed reference intervals for VWFMM were calculated for LMWM 10.4-22.5%, IMWM 22.6-37.6%, HMWM 45.6-66.6%. Age related differences were seen in IMWM and HMWM (p<0.001 and 0.038). There was no gender related difference observed. Geographically LMWM results of France were different from the other regions (p<0.05).

Conclusions:

Quantification of VWFMM fractions, in addition to qualitative assessment of VWFMM patterns, has the potential to aid in differential diagnosis of von Willebrand disease (VWD) subtypes. The reference values calculated in this study can be used in future research to establish clinical decision limits.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: J Med Biochem Año: 2022 Tipo del documento: Article País de afiliación: Estonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: J Med Biochem Año: 2022 Tipo del documento: Article País de afiliación: Estonia